Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of caffeine administration in prevention of bronchopulmonary dysplasia (BPD)
IRCT20160827029535N8Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of caffeine in bronchopulmonary dysplasia (BPD), sponsored by Tehran University of Medical Sciences. Started Oct 2015; status: completed.
02
Drugs
caffeine
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on IRCT20160827029535N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160827029535N8.